EMORY UNIVERSITY

Q3 2015 13F Holdings Report, Restatement, Stock Holdings

Signature - Title: Mary L. Cahill - VP of Investments & CIO
Location: Atlanta, GA
Holdings as of: 30 Sep 2015
Value $: $35,905,000
Num holdings: 20
Filing time: 04 Feb 2016, 13:24:00 UTC
Form type: 13F-HR/A-1 - Restatement
Description: All US holdings of this investor are reported in this report. Top holdings included VWO, VSAT, INCY, ACGL, and BCRX.
Previous filing: Q2 2015 - 13 Aug 2015
Next filing: Q4 2016 - 13 Feb 2017
SEC: View on sec.gov

Sym	Weight	Trade Impact	Company	Class	Share Change	Activity	Value Change $	Value $	* Price $	Shares	Principal

Filing 2015 Q3 - Restatement compared to 2015 Q2 by default. Changes are calculated vs the previous SEC filing.

Compare Q3 2015 to

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name	Title	City, State	Date
Mary L. Cahill	VP of Investments & CIO	Atlanta, Georgia	04 Feb 2016

This Amendment No. 1 to Form 13F is being filed to correct an inadvertent administrative error with respect to the reporting of holdings for Acadia Pharmaceuticals Inc. and Seattle Genetics Inc. listed below.